AI Business LensTHE BUSINESS OF AI, FOR PEOPLE WHO TEACH IT OR LEARN FROM IT
Phys.org — Chemistry · October 24, 2026 · On the brief until November 7, 2026

Scientists demonstrate AI-designed enzyme for drug synthesis

ChemistryPharmacyBiology
THE AI ANGLE
Designing custom enzymes for chemical synthesis

Researchers used an artificial intelligence model called RFD4-Proteina to design synthetic enzymes for manufacturing the HIV drug lenacapavir. Laboratory tests showed the top candidate converted 79 percent of a chiral amine into the target product with high selectivity. Chemists can now generate tailored biocatalysts computationally for complex reactions instead of modifying natural proteins.

Summary written by AI Business Lens with an AI model from the article at phys.org. It is not the article, and the publisher has not reviewed it. For publishers.

THE TEACHING ANGLE
Students can examine how an enzyme active site favors amide bond formation while blocking a competing reaction with excess water.

Read the original at phys.org   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, points to raise, an exercise, and a self-check. All built from the full article. A free account saves stories and gives you three generations. Stories stay on the brief for 14 days. After that this page keeps the link to the original.

More in Chemistry